181 related articles for article (PubMed ID: 35386312)
1. Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery.
Zhang S; Peng B; Chen Z; Yu J; Deng G; Bao Y; Ma C; Du F; Sheu WC; Kimberly WT; Simard JM; Coman D; Chen Q; Hyder F; Zhou J; Sheth KN
Bioact Mater; 2022 Oct; 16():57-65. PubMed ID: 35386312
[TBL] [Abstract][Full Text] [Related]
2. Intracisternal administration of tanshinone IIA-loaded nanoparticles leads to reduced tissue injury and functional deficits in a porcine model of ischemic stroke.
Waters ES; Kaiser EE; Yang X; Fagan MM; Scheulin KM; Jeon JH; Shin SK; Kinder HA; Kumar A; Platt SR; Duberstein KJ; Park HJ; Xie J; West FD
IBRO Neurosci Rep; 2021 Jun; 10():18-30. PubMed ID: 33842909
[TBL] [Abstract][Full Text] [Related]
3. Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles.
Deng G; Ma C; Zhao H; Zhang S; Liu J; Liu F; Chen Z; Chen AT; Yang X; Avery J; Zou P; Du F; Lim KP; Holden D; Li S; Carson RE; Huang Y; Chen Q; Kimberly WT; Simard JM; Sheth KN; Zhou J
Theranostics; 2019; 9(23):6991-7002. PubMed ID: 31660082
[TBL] [Abstract][Full Text] [Related]
4. Brain Targeting, Antioxidant Polymeric Nanoparticles for Stroke Drug Delivery and Therapy.
Wu H; Peng B; Mohammed FS; Gao X; Qin Z; Sheth KN; Zhou J; Jiang Z
Small; 2022 Jun; 18(22):e2107126. PubMed ID: 35306743
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
[TBL] [Abstract][Full Text] [Related]
6. Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies.
Yuan J; Li L; Yang Q; Ran H; Wang J; Hu K; Pu W; Huang J; Wen L; Zhou L; Jiang Y; Xiong X; Zhang J; Zhou Z
ACS Nano; 2021 Oct; 15(10):16076-16094. PubMed ID: 34606239
[TBL] [Abstract][Full Text] [Related]
7. Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma.
Li Y; Wang Y; Gao L; Tan Y; Cai J; Ye Z; Chen AT; Xu Y; Zhao L; Tong S; Sun Q; Liu B; Zhang S; Tian D; Deng G; Zhou J; Chen Q
J Nanobiotechnology; 2022 Jan; 20(1):39. PubMed ID: 35062946
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled targeted folate-conjugated eight-arm-polyethylene glycol-betulinic acid nanoparticles for co-delivery of anticancer drugs.
Dai L; Cao X; Liu KF; Li CX; Zhang GF; Deng LH; Si CL; He J; Lei JD
J Mater Chem B; 2015 May; 3(18):3754-3766. PubMed ID: 32262850
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-Responsive, Brain-Targeting Nanoparticles for Improved Stroke Therapy.
Guo X; Deng G; Liu J; Zou P; Du F; Liu F; Chen AT; Hu R; Li M; Zhang S; Tang Z; Han L; Liu J; Sheth KN; Chen Q; Gou X; Zhou J
ACS Nano; 2018 Aug; 12(8):8723-8732. PubMed ID: 30107729
[TBL] [Abstract][Full Text] [Related]
10. A multifunctional CeO
Chen Z; Xu L; Gao X; Wang C; Li R; Xu J; Zhang M; Panichayupakaranant P; Chen H
Food Res Int; 2020 Nov; 137():109674. PubMed ID: 33233251
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic benefits of nanoparticles in stroke.
Panagiotou S; Saha S
Front Neurosci; 2015; 9():182. PubMed ID: 26041986
[TBL] [Abstract][Full Text] [Related]
12. α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery.
Li Y; Hu H; Zhou Q; Ao Y; Xiao C; Wan J; Wan Y; Xu H; Li Z; Yang X
ACS Appl Mater Interfaces; 2017 Jun; 9(22):19215-19230. PubMed ID: 28513132
[TBL] [Abstract][Full Text] [Related]
13. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.
Wu ZC; Liu XY; Liu JY; Piao JS; Piao MG
Int J Nanomedicine; 2022; 17():4195-4210. PubMed ID: 36134203
[TBL] [Abstract][Full Text] [Related]
15. Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.
Tao R; Wang C; Lu Y; Zhang C; Zhou H; Chen H; Li W
Int J Nanomedicine; 2020; 15():2733-2749. PubMed ID: 32368052
[TBL] [Abstract][Full Text] [Related]
16. Amphiphilic block copolymer NPs obtained by coupling ricinoleic acid/sebacic acids and mPEG: Synthesis, characterization, and controlled release of paclitaxel.
Zhou S; Sun W; Zhai Y
J Biomater Sci Polym Ed; 2018 Dec; 29(18):2201-2217. PubMed ID: 30285542
[TBL] [Abstract][Full Text] [Related]
17. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
18. Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment.
Lu X; Zhang Y; Wang L; Li G; Gao J; Wang Y
Drug Deliv; 2021 Dec; 28(1):380-389. PubMed ID: 33586561
[TBL] [Abstract][Full Text] [Related]
19. Superior antioxidant and anti-ischemic neuroprotective effects of cerebrolysin in heat stroke following intoxication of engineered metal Ag and Cu nanoparticles: A comparative biochemical and physiological study with other stroke therapies.
Sharma HS; Muresanu DF; Ozkizilcik A; Sahib S; Tian ZR; Lafuente JV; Castellani RJ; Nozari A; Feng L; Buzoianu AD; Menon PK; Patnaik R; Wiklund L; Sharma A
Prog Brain Res; 2021; 266():301-348. PubMed ID: 34689862
[TBL] [Abstract][Full Text] [Related]
20. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma.
Ruan C; Liu L; Lu Y; Zhang Y; He X; Chen X; Zhang Y; Chen Q; Guo Q; Sun T; Jiang C
Acta Pharm Sin B; 2018 Jan; 8(1):85-96. PubMed ID: 29872625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
